{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T02:31:59Z","timestamp":1783218719288,"version":"3.54.6"},"reference-count":19,"publisher":"Pharmaceutical Society of Japan","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2020,9,1]]},"DOI":"10.1248\/bpb.b20-00174","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T22:06:09Z","timestamp":1598911569000},"page":"1331-1337","source":"Crossref","is-referenced-by-count":7,"title":["Telmisartan Exacerbates Cisplatin-Induced Nephrotoxicity in a Mouse Model"],"prefix":"10.1248","volume":"43","author":[{"given":"Atsuki","family":"Hosoda","sequence":"first","affiliation":[{"name":"Department of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Setsunan University"},{"name":"Department of Pharmacy, National Hospital Organization, Osaka Minami Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Setsunan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuuki","family":"Toriyama","sequence":"additional","affiliation":[{"name":"Department of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Setsunan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Department of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Setsunan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Setsunan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Masamichi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, National Hospital Organization, Osaka Minami Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeyuki","family":"Kohno","sequence":"additional","affiliation":[{"name":"Department of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Setsunan University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) de Jongh FE, van Veen RN, Veltman SJ, de Wit R, van der Burg ME, van den Bent MJ, Planting AS, Graveland WJ, Stoter G, Verweij J. Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients. <i>Br. J. Cancer<\/i>, <b>88<\/b>, 1199\u20131206 (2003)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Latcha S, Jaimes EA, Patil S, Glezerman IG, Mehta S, Flombaum CD. Long-term renal outcomes after cisplatin treatment. <i>Clin. J. Am. Soc. Nephrol.<\/i>, <b>11<\/b>, 1173\u20131179 (2016).","DOI":"10.2215\/CJN.08070715"},{"key":"3","unstructured":"3) Luke DR, Vadiei K, Lopez-Berestein G. Role of vascular congestion in cisplatin-induced acute renal failure in the rat. <i>Nephrol. Dial. Transplant.<\/i>, <b>7<\/b>, 1\u20137 (1992)."},{"key":"4","unstructured":"4) Komaki K, Kusaba T, Tanaka M, Kado H, Shiotsu Y, Matsui M, Shiozaki A, Nakano H, Ishikawa T, Fujiwara H, Konishi H, Itoh Y, Matoba S. Lower blood pressure and risk of cisplatin nephrotoxicity: a retrospective cohort study. <i>BMC Cancer<\/i>, <b>17<\/b>, 144 (2017)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Saleh S, Ain-Shoka AA, El-Demerdash E, Khalef MM. Protective effects of the angiotensin II receptor blocker losartan on cisplatin-induced kidney injury. <i>Chemotherapy<\/i>, <b>55<\/b>, 399\u2013406 (2009).","DOI":"10.1159\/000262453"},{"key":"6","unstructured":"6) Ma P, Zhang S, Su X, Qiu G, Wu Z. Protective effects of icariin on cisplatin-induced acute renal injury in mice. <i>Am. J. Transl. Res<\/i>, <b>7<\/b>, 2105\u20132114 (2015)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Sasaki S, Takahashi T, Hagiwara A, Tsujimoto H, Osaki K. Acute toxicity of cisplatin microcrystals suspended in oil on intraperitoneal administration in mice. <i>Drug Deliv. Syst.<\/i>, <b>10<\/b>, 111\u2013114 (1995).","DOI":"10.2745\/dds.10.111"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Kanematsu Y, Kanematsu M, Kurihara C, Tsou TL, Nuki Y, Liang EI, Makino H, Hashimoto T. Pharmacologically induced thoracic and abdominal aortic aneurysms in mice. <i>Hypertension<\/i>, <b>55<\/b>, 1267\u20131274 (2010).","DOI":"10.1161\/HYPERTENSIONAHA.109.140558"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Lu H, Balakrishnan A, Howatt DA, Wu C, Charnigo R, Liau G, Cassis LA, Daugherty A. Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis. <i>Br. J. Pharmacol.<\/i>, <b>165<\/b>, 2000\u20132008 (2012).","DOI":"10.1111\/j.1476-5381.2011.01712.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Washida K, Ihara M, Nishio K, Fujita Y, Maki T, Yamada M, Takahashi J, Wu X, Kihara T, Ito H, Tomimoto H, Takahashi R. Nonhypotensive dose of telmisartan attenuates cognitive impairment partially due to peroxisome proliferator-activated receptor-gamma activation in mice with chronic cerebral hypoperfusion. <i>Stroke<\/i>, <b>41<\/b>, 1798\u20131806 (2010).","DOI":"10.1161\/STROKEAHA.110.583948"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Graus-Nunes F, Santos FO, Marinho TS, Miranda CS, Barbosa-da-Silva S, Souza-Mello V. Beneficial effects of losartan or telmisartan on the local hepatic renin\u2013angiotensin system to counter obesity in an experimental model. <i>World J. Hepatol.<\/i>, <b>11<\/b>, 359\u2013369 (2019).","DOI":"10.4254\/wjh.v11.i4.359"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Xia H, Feng Y, Obr TD, Hickman PJ, Lazartigues E. Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice. <i>Hypertension<\/i>, <b>53<\/b>, 210\u2013216 (2009).","DOI":"10.1161\/HYPERTENSIONAHA.108.123844"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Yoshitake I, Sezai A, Shiono M. The recent trends in the use of angiotensin II receptor blockers. <i>J. Nihon Univ. Med. Ass.<\/i>, <b>73<\/b>, 8\u201311 (2014).","DOI":"10.4264\/numa.73.8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Al-Husseiny F, Sobh MA, Ashour RH, Foud S, Medhat T, El-Gilany AH, Elghannam D, Abdel-Ghaffar H, Saad MA, Sobh M. Amniotic fluid-derived mesenchymal stem cells cut short the acuteness of cisplatin-induced nephrotoxicity in Sprague-Dawley rats. <i>Int. J. Stem Cells<\/i>, <b>9<\/b>, 70\u201378 (2016).","DOI":"10.15283\/ijsc.2016.9.1.70"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Abuelo JG. Normotensive ischemic acute renal failure. <i>N. Engl. J. Med.<\/i>, <b>357<\/b>, 797\u2013805 (2007).","DOI":"10.1056\/NEJMra064398"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Hayashi K, Nagahama T, Oka K, Epstein M, Saruta T. Disparate effects of calcium antagonists on renal microcirculation. <i>Hypertens. Res.<\/i>, <b>19<\/b>, 31\u201336 (1996).","DOI":"10.1291\/hypres.19.31"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. Mechanisms of cisplatin nephrotoxicity. <i>Toxins<\/i>, <b>2<\/b>, 2490\u20132518 (2010).","DOI":"10.3390\/toxins2112490"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Terada Y, Inoshita S, Kuwana H, Kobayashi T, Okado T, Ichijo H, Sasaki S. Important role of apoptosis signal-regulating kinase 1 in ischemic acute kidney injury. <i>Biochem. Biophys. Res. Commun.<\/i>, <b>364<\/b>, 1043\u20131049 (2007).","DOI":"10.1016\/j.bbrc.2007.10.122"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Kuwana H, Terada Y, Kobayashi T, Okado T, Penninger JM, Irie-Sasaki J, Sasaki T, Sasaki S. The phosphoinositide-3 kinase gamma-Akt pathway mediates renal tubular injury in cisplatin nephrotoxicity. <i>Kidney Int.<\/i>, <b>73<\/b>, 430\u2013445 (2008).","DOI":"10.1038\/sj.ki.5002702"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/9\/43_b20-00174\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T03:21:12Z","timestamp":1599276072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/9\/43_b20-00174\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b20-00174","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}